Ryboquin raises £1.8m

3 July 2017 / News

Scottish drug developer Ryboquin has raised a further £1.8m to progress development of its gene therapy treatment for cancer. Backers of the Selkirk-based company include existing investors such as Borders business angel group TRI Capital and the Scottish Investment Bank.

Healthtech firm Bioliberty to accelerate international growth with new investment

31 March 2026 / Deals, News

Healthtech firm, Bioliberty, has secured a total of £7.7m of funding over the last 10 months. The most recent £6.2m Series A investment was led…

Earth Blox secures £6m to help businesses and banks finance the transition to a nature-positive economy

31 March 2026 / Deals, News

Earth Blox, an Edinburgh-based technology company helping organisations understand how nature loss and climate hazards affect financial performance, has secured £6 million in new investment…

Kelvin Capital launches new SME-focused investment fund

17 March 2026 / News

Kelvin Capital, the Scottish based investment syndicate, has launched The Kelvin Capital Catalyst Fund, a new investment platform focused on deploying strategic capital into established,…

Angel Capital Scotland is the national association for business angels in Scotland.

We support collaboration across the angel investment sector, including syndicates, individual investors and industry partners.

Navigation

Home
About
Investors
Entrepreneurs

Member Directory
News
Events
Members Only

Get in Touch

info@angelcapital.scot

Contact Us

[gravityform id=”2″ title=”false” ajax=”true”]

Related Posts